| Capot Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8558-6718 +86 13336195806 | |||
![]() |
capotchem@gmail.com sales@capotchem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2006 | ||||
| Simagchem Corporation | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 13806087780 | |||
![]() |
sale@simagchem.com | |||
| Chemical manufacturer since 2002 | ||||
| chemBlink standard supplier since 2008 | ||||
| Taizhou Crene Biotechnology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (576) 8881-3233 8820-5808 +86 13396860566 | |||
![]() |
order@pharm-intermediates.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink standard supplier since 2009 | ||||
| Changzhou Carbochem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (519) 8918-1862 +86 13775204319 | |||
![]() |
gao@carbo-chem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer since 2009 | ||||
| chemBlink standard supplier since 2010 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Jinan Trio PharmaTech Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (531) 8881-1783 8881-1793 8880-6178 | |||
![]() |
trio@trio-pharmatech.com sales@trio-pharmatech.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2011 | ||||
| China Jintai Biocompound Company | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (755) 8526-9922 | |||
![]() |
sales@shengdapharm.com | |||
| Chemical manufacturer since 2011 | ||||
| chemBlink standard supplier since 2012 | ||||
| Active biopharma Corp | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8161-2335 | |||
![]() |
support@activebiopharma.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2012 | ||||
| Classification | API >> Inhibitor drug |
|---|---|
| Name | Crizotinib |
| Synonyms | PF-02341066; 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine; PF 2341066 |
| Molecular Structure | ![]() |
| Molecular Formula | C21H22Cl2FN5O |
| Molecular Weight | 450.34 |
| CAS Registry Number | 877399-52-5 |
| EC Number | 638-814-9 |
| Hazard Classification | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Crizotinib |